During the three and nine months ended March 31, 2026, the Company recorded impairment and restructuring charges of $18 million and $67 million, including restructuring charges of $14 million and $50 million, respectively.

During the three and nine months ended March 31, 2025, the Company recorded impairment and restructuring charges of $13 million and $51 million, including restructuring charges of $11 million and $49 million, respectively.


	For the three months ended March 31,
	2026				2025
	One time employee termination benefits		Other costs		Total		One time employee termination benefits		Other costs		Total
	(in millions)
Balance, beginning of period	$	21	$	45	$	66	$	18	$	31	$	49
Additions	14		—		14		11		—		11
Payments	(14)		(1)		(15)		(12)		(3)		(15)
Other	(1)		(1)		(2)		(1)		1		—
Balance, end of period	$	20	$	43	$	63	$	16	$	29	$	45


	For the nine months ended March 31,
	2026				2025
	One time employee termination benefits		Other costs		Total		One time employee termination benefits		Other costs		Total
	(in millions)
Balance, beginning of period	$	42	$	46	$	88	$	25	$	34	$	59
Additions	49		1		50		47		2		49
Payments	(74)		(4)		(78)		(54)		(7)		(61)
Other	3		—		3		(2)		—		(2)
Balance, end of period	$	20	$	43	$	63	$	16	$	29	$	45

As of March 31, 2026, restructuring liabilities of $23 million were included in the Balance Sheet in Other current liabilities and $40 million were included in Other non-current liabilities.